Globus Medical (GMED)
(Delayed Data from NYSE)
$57.84 USD
-0.40 (-0.69%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $57.82 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Globus Medical, Inc. has a PEG ratio of 1.58 compared to the Medical - Instruments industry's PEG ratio of 2.51.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GMED 57.84 -0.40(-0.69%)
Will GMED be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMED
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?
Other News for GMED
Is GMED positioned for a breakout? 50 Day Moving Average Support shows up after dropping 0.69%
GMED forms Stochastic Buy Signal on September 15
Insider Sell: Ann Rhoads Sells 10,000 Shares of Globus Medical Inc (GMED)
GMED falls 1.48% on September 12, leaving the technical picture intact
Bullish Engulfing appears for GMED after 2.02% move